Trial intelligence / Profile preview

HiCM-188 Chitosan Patch in Severe Chronic Ischemic Heart Disease

NCT07471698Phase 2Not yet recruiting

Sponsor
Help Therapeutics
Start
Oct 2026
Primary completion
Oct 2028
Modality
Patient-derived iPSCs, Allogeneic iPSCs
Countries
1
01

Overview

A Phase 2 trial of HiCM-188 in Ischemic Heart Failure (IHF), sponsored by Help Therapeutics. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

HiCM-188
03

Conditions

Ischemic Heart Failure (IHF)

Beyond the preview

Go deeper on NCT07471698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07471698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call